Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium

Canadian Journal of Anesthesia

Volumn 50, Issue 9, 2003, Pages 879-885

  Suzuki, Takahiro ^a,b   Lien, Cynthia A ^a   Belmont, Matthew R ^a   Tjan, Joseph ^a   Savarese, John J ^a  

^a Department of Obstetrics Gynecology   (United States)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CISATRACURIUM; EDROPHONIUM; FENTANYL; MIDAZOLAM; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE PLUS OXYGEN; PROPOFOL; RAPACURONIUM BROMIDE; ROCURONIUM;

ADULT; ANESTHETIC RECOVERY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFICACY; ELECTIVE SURGERY; HUMAN; LARYNX MUSCLE; MAJOR CLINICAL STUDY; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT LARYNGEAL NERVE; STATISTICAL ANALYSIS; TIME; UROLOGIC SURGERY;

EID: 0942288005     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018732     Document Type: Article

References (36)

1. Donati F, Antzaka C, Bevan DR. Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 1986; 65: 1-5.
2. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. Anesthesiology 1991; 74: 833-7.
3. Laycock JR, Donati F, Smith CE, Bevan DR. Potency of atracurium and vecuronium at the diaphragm and the adductor pollicis muscle. Br J Anaesth 1988; 61: 286-91.
4. Lebrault C, Chauvin M, Guirimand F, Duvaldestin P. Relative potency of vecuronium on the diaphragm and the adductor pollicis. Br J Anaesth 1989; 63: 389-92.
5. Rupp SM, McChristian JW, Miller RD, Taboada JA, Cronnelly R. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium. Anesthesiology 1986; 64: 711-7.
6. Beemer GH, Bjorksten AR, Dawson PJ, Dawson RJ, Heenan PJ, Robertson BA. Determinants of the reversal time of competitive neuromuscular block by anti-cholinesterases. Br J Anaesth 1991; 66: 469-75.
7. Hennart D, D'Hollander A, Plasman C, De Jonckheere M. Importance of the level of paralysis recovery for a rapid antagonism of atracurium neuromuscular blockade with moderate doses of edrophonium. Anesthesiology 1986; 64: 384-7.
8. Ali HH, Wilson RS, Savarese JJ, Kitz RJ. The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth 1975; 47: 570-4.
9. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997; 86: 765-71.
10. Pavlin EG, Holle RH, Schoene RB. Recovery of airway protection compared with ventilation in humans after paralysis with curare. Anesthesiology 1989; 70: 381-5.
11. Pansard JL, Chauvin M, Lebrault C, Gauneau P, Duvaldestin P. Effect of an intubating dose of succinylcholine and atracurium on the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 1987; 67: 326-30.
12. Donati F, Plaud B, Meistelman C. A method to measure elicited contraction of laryngeal adductor muscles during anesthesia. Anesthesiology 1991; 74: 827-32.
13. Cronnelly R, Morris RB, Miller RD. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia. Anesthesiology 1982; 57: 261-6.
14. Morris RB, Cronnelly R, Miller RD, Stanski DR, Fahey MR. Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man. Anesthesiology 1981; 54: 399-402.
15. Beemer GH, Goonetilleke PH, Bjorksten AR. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery. Anesthesiology 1995; 82: 852-8.
16. Bartkowski RR. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium. Anesth Analg 1987; 66: 594-8.
17. Brandom BW, Taiwo OO, Woelfel SK, Schon H, Gronert BJ, Cook DR. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium. Anesth Analg 1996; 82: 999-1002.
18. Kao YJ, Le ND. The reversal of profound mivacurium-induced neuromuscular blockade. Can J Anaesth 1996; 43: 1128-33.
19. Devcic A, Munshi CA, Gandhi SK, Kampine JP. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium. Anesth Analg 1995; 81: 1005-9.
20. Bevan JC, Tousignant C, Stephenson C, et al. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children. Anesthesiology 1996; 84: 354-61.
21. Hart PS, Wright PM, Brown R, et al. Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis. Anesthesiology 1995; 82: 912-8.
22. Yost CS, Maestrone E. Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor. Anesth Analg 1994; 78: 520-6.
23. Engbaek J, Ording H, Ostergaard D, Viby-Mogensen J. Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium. Acta Anaesthesiol Scand 1985; 29: 544-6.
24. Mirakhur RK, Gibson FM, Lavery GG. Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine. Br J Anaesth 1987; 59: 473-7.
25. Donati F, Smith CE, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade. Anesth Analg 1989; 68: 13-9.
26. Magorian TT, Lynam DP, Caldwell JE, Miller RD. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? Anesthesiology 1990; 73: 410-4.
27. Trevien V, Lienhart A, Just B, Chandon M, Baras E, Camatte S. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade. Acta Anaesthesiol Scand 1995; 39(Suppl 106): 66-9.
28. Engbaek J, Ostergaard D, Skovgaard LT, Viby-Mogensen J. Reversal of intense neuromuscular blockade following infusion of atracurium. Anesthesiology 1990; 72: 803-6.
29. Bragg P, Fisher DM, Shi J, et al. Comparison of twitch depression of the adductor pollicis and the respiratory muscles: pharmacodynamic modeling without plasma concentrations. Anesthesiology 1994; 80: 310-9.
30. Mills KG, Wright PM, Pollard BJ, et al. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics. Br J Anaesth 1999; 83: 727-33.
31. Purdy R, Bevan DR, Donati F, Lichtor JL. Early reversal of rapacuronium with neostigmine. Anesthesiology 1999; 91: 51-7.
32. Gisiger V, Stephens H. Acetylcholinesterase content in both motor nerve and muscle is correlated with twitch properties. Neurosci Lett 1982; 31: 301-5.
33. Morales J, Rama J, Gayoso M. Some aspects of nerve endings and synapses in the vocalis muscle. J Laryngol Otol 1980; 94: 1047-63.
34. Eriksson LI, Lennmarken C, Wyon N, Johnson A. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block. Acta Anaesthesiol Scand 1992; 36: 710-5.
35. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans. Simultaneous video-manometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 87: 1035-43.
36. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92: 977-84.